Analysis of Using Low Dose 3 Factor PCC (Bebulin®) for INR Reversal in Patients with Warfarin Induced Severe/Life-Threatening Bleeding
Autor: | Mekan, Sabeen F. *, Logdberg, Lennart, Stein, Arline *, Nash, Leah *, Cohen, Jessica *, Rosenberg, David * |
---|---|
Zdroj: | In Blood 6 December 2014 124(21):5043-5043 |
Databáze: | ScienceDirect |
Externí odkaz: |